Global Initiative on Obstructive Lung Disease (GOLD) classification of lung disease and mortality: Findings from the Atherosclerosis Risk in Communities (ARIC) study

Respiratory Medicine

Volumn 100, Issue 1, 2006, Pages 115-122

  Mannino, David M ^a,b   Doherty, Dennis E ^a,b   Buist, A Sonia ^c  

^a UNIVERSITY OF KENTUCKY   (United States)

^b LEXINGTON VA MEDICAL CENTER   (United States)

^c OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Cohort study; COPD; GOLD classification; Lung function; Mortality; Smoking

Indexed keywords

ADULT; AGED; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COHORT ANALYSIS; CONFIDENCE INTERVAL; DISEASE CLASSIFICATION; DISEASE SEVERITY; FEMALE; FOLLOW UP; FORCED EXPIRATORY VOLUME; HIGH RISK PATIENT; HUMAN; LINEAR REGRESSION ANALYSIS; LUNG FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; MORTALITY; NONBIOLOGICAL MODEL; POPULATION RESEARCH; PREDICTION; PRIORITY JOURNAL; RISK ASSESSMENT; SPIROMETRY; UNITED STATES;

ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; AGED; AMERICAS; COHORT STUDIES; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RISK FACTORS; SEVERITY OF ILLNESS INDEX; VITAL CAPACITY;

EID: 29944439589     PISSN: 09546111     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rmed.2005.03.035     Document Type: Article

References (40)

1. D.M. Mannino D.M. Homa L. Akinbami E.S. Ford S.C. Redd Surveillance for Chronic Obstructive Pulmonary Disease-United States, 1971-2000 MMWR CDC Surveillance Summaries 51 6 2002 1-16
2. T.E. King Jr Respiratory bronchiolitis-associated interstitial lung disease Clin Chest Med 14 1993 693-698
3. S.E. Gay E.A. Kazerooni G.B. Toews et al. Idiopathic pulmonary fibrosis: predicting response to therapy and survival Am J Respir Crit Care Med 157 1998 1063-1072
4. C.S. Ulrik V. Backer Nonreversible airflow obstruction in life-long nonsmokers with moderate to severe asthma Eur Respir J 14 1999 892-896
5. M.R. Becklake Chronic airflow limitation: Its relationship to work in dusty occupations Chest 88 1985 608-617
6. J.C. Hogg Chronic bronchitis: The role of viruses Semin Respir Infect 15 2000 32-40
7. M. Kraft G.H. Cassell J.E. Henson Detection of Mycoplasma pneumoniae in the airways of adults with chronic asthma Am J Respir Crit Care Med 158 1998 998-1001
8. A.E. Camilli D.R. Robbins M.D. Lebowitz Death certificate reporting of confirmed airways obstructive disease Am J Epidemiol 133 1991 795-800
9. D.M. Mannino A.S. Buist T.L. Petty P.L. Enright S.C. Redd Lung function and mortality in the United States: Data from the First National Health and Nutrition Examination Survey follow up study Thorax 58 2003 388-393
10. J. Danesh M.B. Pepys C-reactive protein in healthy and in sick populations Eur Heart J 21 2000 1564-1565
11. R. Nijmeijer W.K. Lagrand C.A. Visser C.J. Meijer H.W. Niessen C.E. Hack CRP, a major culprit in complement-mediated tissue damage in acute myocardial infarction? Int Immunopharmacol 1 2001 403-414
12. D.M. Mannino E.S. Ford S.C. Redd Obstructive and restrictive lung disease and markers of inflammation: Data from the Third National Health and Nutrition Examination Am J Med 114 2003 758-762
13. D.D. Sin S.F. Man Impaired lung function and serum leptin in men and women with normal body weight: A population based study Thorax 58 2003 695-698
14. D.S. Postma H.J. Sluiter Prognosis of chronic obstructive pulmonary disease: The Dutch experience Am Rev Respir Dis 140 1989 S100-S105
15. L.M. Neas J. Schwartz Pulmonary function levels as predictors of mortality in a national sample of US adults Am J Epidemiol 147 1998 1011-1018
16. N.R. Anthonisen Prognosis in chronic obstructive pulmonary disease: results from multicenter clinical trials Am Rev Respir Dis 140 1989 S95-S99
17. J.J. Hospers D.S. Postma B. Rijcken S.T. Weiss J.P. Schouten Histamine airway hyper-responsiveness and mortality from chronic obstructive pulmonary disease: A cohort study Lancet 356 2000 1313-1317
18. D.J. Hole G.C. Watt G. Davey-Smith C.L. Hart C.R. Gillis V.M. Hawthorne Impaired lung function and mortality risk in men and women: Findings from the Renfrew and Paisley prospective population study BMJ 313 1996 711-715
19. M.W. Knuiman A.L. James M.L. Divitini G. Ryan H.C. Bartholomew A.W. Musk Lung function, respiratory symptoms, and mortality: Results from the Busselton Health Study Ann Epidemiol 9 1999 297-306
20. H.J. Schunemann J. Dorn B.J. Grant W. Winkelstein Jr M. Trevisan Pulmonary function is a long-term predictor of mortality in the general population: 29-year follow-up of the Buffalo Health Study Chest 118 2000 656-664
21. R.A. Pauwels A.S. Buist P.M. Calverley C.R. Jenkins S.S. Hurd Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) workshop summary Am J Respir Crit Care Med 163 2001 1256-1276
22. The Atherosclerosis Risk in Communities (ARIC) Study: Design and objectives The ARIC investigators Am J Epidemiol 129 1989 687-702 702
23. American Thoracic Society Standardization of spirometry Am Rev Respir Dis 119 1979 831-838 838
24. American Thoracic Society Standardization of spirometry, 1994 update Am J Respir Crit Care Med 152 1995 1107-1136 1136
25. Executive summary of the clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults Arch Intern Med 158 1998 1855-1867 1867
26. G. Engstrom B. Hedblad L. Janzon S. Valind Respiratory decline in smokers and ex-smokers-an independent risk factor for cardiovascular disease and death J Cardiovasc Risk 7 2000 267-272
27. D.D. Sin S.F. Man Why are patients with chronic obstructive pulmonary disease at increased risk of cardiovascular diseases? The potential role of systemic inflammation in chronic obstructive pulmonary disease Circulation 107 2003 1514-1519
28. D.M. Mannino S.M. Aguayo T.L. Petty S.C. Redd Low lung function and incident lung cancer in the United States: Data from the First National Health and Nutrition Examination Survey follow-up Arch Intern Med 163 2003 1475-1480
29. D.S. Sharp K. Masaki C.M. Burchfiel K. Yano I.J. Schatz Prolonged QTc interval, impaired pulmonary function, and a very lean body mass jointly predict all-cause mortality in elderly men Ann Epidemiol 8 1998 99-106
30. A.G. Stewart J.C. Waterhouse P. Howard The QTc interval, autonomic neuropathy and mortality in hypoxaemic COPD Respir Med 89 1995 79-84
31. M. Volterrani S. Scalvini G. Mazzuero et al. Decreased heart rate variability in patients with chronic obstructive pulmonary disease Chest 106 1994 1432-1437
32. F. Maltais P. LeBlanc J. Jobin R. Casaburi Peripheral muscle dysfunction in chronic obstructive pulmonary disease Clin Chest Med 21 2000 665-677
33. I. Rahman W. MacNee Oxidant/antioxidant imbalance in smokers and chronic obstructive pulmonary disease Thorax 51 1996 348-350
34. J.E. Repine A. Bast I. Lankhorst Oxidative stress in chronic obstructive pulmonary disease. Oxidative Stress Study Group Am J Respir Crit Care Med 156 1997 341-357
35. D. Kohler J. Fischer F. Raschke B. Schonhofer Usefulness of GOLD classification of COPD severity Thorax 58 2003 825
36. B.R. Celli C.G. Cote J.M. Marin et al. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease N Engl J Med 350 2004 1005-1012
37. R. Pistelli P. Lange D.L. Miller Determinants of prognosis of COPD in the elderly: Mucus hypersecretion, infections, cardiovascular comorbidity Eur Respir J Suppl 40 2003 10s-14s
38. J. Vestbo P. Lange Can GOLD Stage 0 provide information of prognostic value in chronic obstructive pulmonary disease? Am J Respir Crit Care Med 166 2002 329-332
39. American Thoracic Society Lung function testing: Selection of reference values and interpretive strategies Am Rev Respir Dis 144 1991 1202-1218
40. S.D. Aaron R.E. Dales P. Cardinal How accurate is spirometry at predicting restrictive pulmonary impairment? Chest 115 1999 869-873